Products Categories
CAS No.: | 15351-09-4 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Name: | Metamfepramone | ||||||||
Article Data: | 17 | ||||||||
Molecular Structure: | |||||||||
Formula: | C11H15 N O | ||||||||
Molecular Weight: | 177.246 | ||||||||
Synonyms: | Propiophenone,2-(dimethylamino)- (6CI,7CI,8CI); 2-(Dimethylamino)propiophenone;Dimethylpropion; MG 559; Metamfepramone; Metamfepyramone; N-Methylephedrone;NSC 234706; UR 1430; a-(Dimethylamino)propiophenone | ||||||||
EINECS: | 239-384-1 | ||||||||
Density: | 0.995g/cm3 | ||||||||
Boiling Point: | 256.6°C at 760 mmHg | ||||||||
Flash Point: | 84.9°C | ||||||||
Hazard Symbols: | |||||||||
Risk Codes: | 20/21/22 | ||||||||
Safety: |
|
||||||||
PSA: | 20.31000 | ||||||||
LogP: | 1.81940 |
Molecular Structure of Metamfepramone (CAS NO.15351-09-4):
Molecular Formula: C11H15NO
Molecular Weight: 177.2429
IUPAC Name: 2-(Dimethylamino)-1-phenylpropan-1-one
Synonyms of Metamfepramone (CAS NO.15351-09-4): 2-(Dimethylamino)-1-phenyl-1-propanone ; 2-(Dimethylamino)propiophenone ; 4-14-00-00143 (Beilstein Handbook Reference) ; AI3-50560 ; BRN 3197828 ; EINECS 239-384-1 ; MG 559 ; Metamfepramona ; Metamfepramona [Spanish] ; Metamfepramone ; Metamfepramonum ; Metamfepramonum [INN-Latin] ; Metamfepramonum [Latin] ; Metanfepramona ; Metanfepramona [INN-Spanish] ; NSC 234706 ; UNII-04A0P12FH2 ; alpha-Dimethylaminopropiophenone ; 1-Propanone, 2-(dimethylamino)-1-phenyl- (9CI) ; Propiophenone, 2-(dimethylamino)-
CAS NO: 15351-09-4
Classification Code: Drug / Therapeutic Agent ; Human Data
Index of Refraction: 1.516
Molar Refractivity: 53.85 cm3
Molar Volume: 178.1 cm3
Surface Tension: 35.5 dyne/cm
Density: 0.995 g/cm3
Flash Point: 84.9 °C
Enthalpy of Vaporization: 49.41 kJ/mol
Boiling Point: 256.6 °C at 760 mmHg
Vapour Pressure: 0.0152 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | oral | 7143ug/kg (7.143mg/kg) | AUTONOMIC NERVOUS SYSTEM: SYMPATHOMIMETIC BEHAVIORAL: TREMOR VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION | Therapie. Vol. 34, Pg. 205, 1979. |
Hazard Codes of Metamfepramone (CAS NO.15351-09-4): Xn
Risk Statements: 20/21/22
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36: Wear suitable protective clothing.
RTECS: UH0539900